SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 13.31 |
| Enterprise Value ($M) | 4.92 |
| Book Value ($M) | 46.81 |
| Book Value / Share | 1.22 |
| Price / Book | 0.28 |
| NCAV ($M) | 3.46 |
| NCAV / Share | 0.09 |
| Price / NCAV | 3.85 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.89 |
| Return on Assets (ROA) | -0.44 |
| Return on Equity (ROE) | -0.61 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.13 |
| Current Ratio | 3.13 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 42.51 |
| Assets | 85.86 |
| Liabilities | 39.05 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 7.69 |
| Operating Income | -68.24 |
| Net Income | -63.12 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -61.29 |
| Cash from Investing | 57.58 |
| Cash from Financing | 0.11 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Citadel Advisors Llc | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 21,951 | 191,499 | 11.46 | |
| 10,777 | 37,753 | 28.55 | |
| 11,236 | 62,104 | 18.09 | |
| 38,057 | 85,728 | 44.39 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BIVI – BioVie Inc. | BMRA – Biomerica, Inc. |
| BNTC – Benitec Biopharma Inc. | BON – Bon Natural Life Limited |
| BTAI – BioXcel Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io